Site Search
Recent Posts
Newsletter Sign Up
Categories
- General (2)
- Research (68)
- Gene Therapy (30)
- Stem Cell (23)
- Pharmaceuticals (19)
- Genetics (15)
- Prosthetics (17)
- Diseases (62)
- AMD (35)
- Retinitis pigmentosa (36)
- Stargardt disease (32)
- Usher syndrome (34)
- LCA (27)
- Other diseases (23)
- Support (13)
- News Commentary (15)
- FFB on the Road (29)
- VISIONS (11)
- Guest Bloggers (12)
- Reader Questions Answered (2)
Archives
Blogroll
Tags
advanced cell technology
age-related macular degeneration
artificial retina
arvo
bascom palmer eye institute
clinical trials
cochlear implant
dha
dining in the dark
fda
food and drug administration
gene-correction
genentech
genetic testing
hadassah
ipsc
israel
lca
leber congenital amaurosis
mainz university
mobility
mutated genes
oshu
oxford biomedica
proteins
rabin medical center
radboud university
retina foundation of the southwest
retina implant ag
retinal imaging
retinitis pigmentosa
ribosomes
rods
rp
second sight
stargardt disease
Stem Cells
technology
transplantation
university of california
university of wisconson-madison
usher syndrome
visions
vitamin a
wills eye institute
Posts Tagged ‘AGTC’
Israeli Research Group Receives $1.33 Million to Advance Stem Cell Treatment
02Aug
Author: Dr. Steve Rose 3 comments
I was heartened to just learn that researchers from the Hadassah-Hebrew Medical Center in Jerusalem are receiving a $1.33 million grant from the Israeli government to advance their development of a stem cell treatment for people with dry age-related macular degeneration (AMD Hadassah is also funded by the Foundation Fighting Blindness. We are providing the group with a three-year, $300,000 grant for development of stem cell therapies.







